Pre-cessation nicotine replacement therapy: Pragmatic randomized trial

Addiction

Volumn 105, Issue 8, 2010, Pages 1474-1483

  Bullen, Chris ^a   Howe, Colin ^a   Lin, Ruey Bin ^a   Grigg, Michele ^b   Laugesen, Murray ^c   McRobbie, Hayden ^d   Glover, Marewa ^e   Walker, Natalie ^a   Wallace Bell, Mark ^f   Whittaker, Robyn ^a   Rodgers, Anthony ^g  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Quit Group   (New Zealand)

^c Health New Zealand Ltd   (New Zealand)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e Faculty of Medical and Health Sciences School of Population Health   (New Zealand)

^f UNIVERSITY OF CANTERBURY   (New Zealand)

^g GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

Author keywords

Cessation; clinical trial; nicotine replacement therapy; pragmatic; pre cessation; quit; randomized; smoking

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ABORIGINE; ADULT; ALGORITHM; ARTICLE; CHEWING GUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; META ANALYSIS; METHODOLOGY; NEW ZEALAND; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; STATISTICS; TELEPHONE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; ALGORITHMS; CHEWING GUM; FEMALE; HOTLINES; HUMANS; MALE; NEW ZEALAND; NICOTINE; NICOTINIC AGONISTS; OCEANIC ANCESTRY GROUP; PATIENT ACCEPTANCE OF HEALTH CARE; SMOKING; SMOKING CESSATION; STATISTICS AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 77954484646     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02989.x     Document Type: Article

References (32)

1. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008 1 : CD000146.
2. Fiore M. C., Jaen C. R., Baker T. B., Bailey W. C., Benowitz N. L., Curry S. J. et al. Treating Tobacco Use and Dependence: 2008 Update.
3. Etter J.-F., Stapleton J. A. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006 15 : 280 285.
4. Rose J., Behm F., Westman E., Levin E., Stein R., Ripka G. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 1994 56 : 86 99.
5. Herrera N., Franco R., Herrera L., Partidas A., Rolando R., Fagerström K. O. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995 108 : 447 451.
6. Rose J. E., Behm F. M., Westman E. C. Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Exp Clin Psychopharmacol 1998 6 : 331 343.
7. Schuurmans M. M., Diacon A. H., Van Biljon X., Bolliger C. T. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Addiction 2004 99 : 634 640.
8. Rose J., Behm F., Westman E., Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 2006 8 : 89 101.
9. Shiffman S., Ferguson S. G. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 2008 103 : 557 563.
10. Rose J., Herskovic J., Behm F., Westman E. Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Poster presented at the Annual Meeting of the Society for Research on Nicotine and Tobacco, Austin, Texas, USA, 2007.
11. Rose J., Herskovic J., Behm F., Westman E. Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 2009 11 : 1067 1075.
12. Fagerström K., Hughes J. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement. Nicotine Tob Res 2002 4 : 73 9.
13. Etter J.-F., Huguelet P., Perneger T. V., Cornuz J. Nicotine gum treatment before smoking cessation: a randomized trial. Arch Intern Med 2009 169 : 1028 1034.
14. Zhu S. H., Anderson C. M., Tedeschi G. J., Rosbrook B., Johnson C. E., Byrd M. et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med 2002 347 : 1087 1093.
15. Stead L. F., Lancaster T., Perera R. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2004 CD002850.
16. Bullen C., Howe C., Grigg M., Phillips F., Silcock R., Glover M. et al. Recruitment into a cessation trial via the New Zealand Quitline: many benefits, few limitations. J Smoking Cessation 2008 3 : 30 4.
17. Grigg M., Glasgow H. Subsidised nicotine replacement therapy. Tob Control 2003 12 : 238 239.
18. The Quit Group, Ministry of Health. Mori Smoking and Tobacco Use. Fact Sheet 1.
19. Bramley D., Riddell T., Whittaker R., Corbett T., Lin R. B., Wills M. et al. Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori. NZ Med J 2005 118.
20. Holt S., Timu-Parata C., Ryder-Lewis S., Weatherall M., Beasley R. Efficacy of bupropion in the indigenous Maori population of New Zealand. Thorax 2005 60 : 120 123.
21. Heatherton T., Kozlowski L., Frecker R., Fagerström K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991 86 : 1119 1127.
22. White S. J., Freedman L. S. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 1978 37 : 849 857.
23. McRobbie H., Bullen C., Glover M., Whittaker R., Wallace-Bell M., Fraser T. New Zealand smoking cessation guidelines. NZ Med J 2008 121 : 57 70.
24. West R., Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl) 2004 177 : 195 199.
25. Jones E. E., Sigall H. The bogus pipeline: a new paradigm for measuring affect and attitude. Psychopharmacol Bull 1971 76 : 349 364.
26. Cooke F., Bullen C., Whittaker R., McRobbie H., Chen M.-H., Walker N. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res 2008 10 : 607 612.
27. National Centre for Classification in Health. ICD-10-AM.
28. Li J. How Do Quitline Callers Compare to the New Zealand Smoking Population?
29. Ministry of Health. New Zealand Tobacco Use Survey 2006.
30. Martin R. J., Togerson D. J. Understanding controlled trials: what are pragmatic trials? BMJ 1998 316 : 285.
31. The Quit Group. New Quitline Service Evaluation: Longitudinal Survey.
32. Stapleton J. A., Russell M. A., Feyerabend C., Wiseman S. M., Gustavsson G., Sawe U. et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995 90 : 31 42.